Bionano Genomics (BNGO) Insider Trading & Ownership $3.78 +0.01 (+0.13%) As of 12:13 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bionano Genomics (NASDAQ:BNGO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.60%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$92,670.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$71,676.00 Get BNGO Insider Trade Alerts Want to know when executives and insiders are buying or selling Bionano Genomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BNGO Insider Buying and Selling by Quarter Bionano Genomics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/13/2023Hannah MamuszkaDirectorBuy109$456.00$49,704.00 5/16/2023R. Erik HolmlinCEOBuy25$384.00$9,600.00 5/12/2023Christopher P StewartCFOBuy83$402.00$33,366.00 8/15/2022Yvonne LinneyDirectorSell33$2,172.00$71,676.00 (Data available from 1/1/2013 forward) BNGO Insider Trading Activity - Frequently Asked Questions Who is on Bionano Genomics's Insider Roster? The list of insiders at Bionano Genomics includes Christopher P Stewart, Hannah Mamuszka, R. Erik Holmlin, and Yvonne Linney. Learn more on insiders at BNGO. What percentage of Bionano Genomics stock is owned by insiders? 1.60% of Bionano Genomics stock is owned by insiders. Learn more on BNGO's insider holdings. Which Bionano Genomics insiders have been buying company stock? The following insider purchased BNGO shares in the last 24 months: Hannah Mamuszka ($49,704.00). How much insider buying is happening at Bionano Genomics? Insiders have purchased a total of 109 BNGO shares in the last 24 months for a total of $49,704.00 bought. Bionano Genomics Key ExecutivesDr. Robert Erik Holmlin M.B.A. (Age 56)Ph.D., President, CEO & Director Compensation: $612.62kMr. Mark Oldakowski (Age 50)Chief Operating Officer Compensation: $472.91kDr. Alka Chaubey FACMG (Age 51)Ph.D., Chief Medical Officer Compensation: $452.91kMs. Gulsen Kama M.B.A. (Age 51)Chief Financial Officer Mr. Mark Adamchak CPAVP of Accounting & ControllerMr. Jonathan Dixon J.D. (Age 49)General Counsel & Secretary Mr. Stanislas Marin M.B.A.M.S., Vice President of Global SalesMs. Donna PolizioGlobal Head of Market AccessMr. Cory KreeckGlobal Head of People OperationsDr. Klint Rose Ph.D.Head of Research & Development More Insider Trading Tools from MarketBeat Related Companies Autoscope Technologies Insider Transactions ClearSign Technologies Insider Transactions Data I/O Insider Transactions Precipio Insider Transactions Astrotech Insider Transactions Talis Biomedical Insider Transactions Accelerate Diagnostics Insider Transactions Spectaire Insider Transactions ThermoGenesis Insider Transactions Trane Technologies Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Meta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears This page (NASDAQ:BNGO) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BNGO Stock Free BNGO Stock Alerts